NEOS News and Press, Neos Therapeutics Inc. From 05/11/20

Neos Therapeutics (NASDAQ: NEOS ): Q1 GAAP EPS of -$0.16 misses by $0.07 . Revenue of $14.49M (-1.0% Y/Y) misses by $0.23M . Press Release More news on: Neos Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,

– Company announces reduction in force to streamline costs and accelerate the path to profitability, particularly in light of the business impact from the COVID-19 pandemic – – Company to host conference call today at 5:00 p.m. EDT – DALLAS and FORT WO...

DALLAS and FORT WORTH, Texas, May 04, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its first quarter 2020 financial results...

Neos Therapeutics ( NEOS ) made some hard choices over the last two years. The change at the top brought a change in strategic direction. The company cut costs viciously and decided to end unfavorable contracts with payers to boost the net price per pack (prescription) for its ADHD products ...

The USPTO has issued Neos Therapeutics (NASDAQ: NEOS ), U.S. Patent No. 10,610,507, directed to the methods of treating sialorrhea by administering N-desethyloxybutynin, the active pharmaceutical ingredient in NT0502. More news on: Neos Therapeutics, Inc., Healthcare stocks news, ...

DALLAS and FORT WORTH, Texas, April 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that the United States Patent and Trademark Office (U...

DALLAS and FORT WORTH, Texas, March 30, 2020 (GLOBE NEWSWIRE) -- Jerry McLaughlin, President and CEO, made the following statement: We want to share the steps we are taking to ensure healthcare providers and patients continue to receive support from Neos Therapeutics and that we are doin...

Gainers:  Champions Oncology (NASDAQ: CSBR ) +38% . More news on: Champions Oncology, Inc., PFSweb, Inc., Mayville Engineering Company, Inc., Stocks on the move, , Read more ...

Neos Therapeutics, Inc. (NEOS) Q4 2019 Earnings Conference Call March 13, 2020 8:30 AM ET Company Participants Richard Eisenstadt - Chief Financial Officer Jerry McLaughlin - Chief Executive Officer Conference Call Participants Louise Chen - Cantor Ken Cacciatore - Cowen a...

Neos Therapeutics (NASDAQ: NEOS ): Q4 GAAP EPS of -$0.07 misses by $0.04 . More news on: Neos Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...